<html>
<head>
<title>rescue page</title>
<style>
.e1{
float:left;
}
.e2{
float:right;
}
.c1{
float:left;
padding:10px;
margin-top:20px;
}
*{
padding:0;
margin:20px;
}
p{
font-size:25px;
}
.d1{
float:left;
}
.d2{
float:right;
}
.d3{
float:right;
}
.d4{
float:left;
}
body{
background-color:#EDF;
background-repeat-no repeat;

}
#grad{
height:4300px;
background-image: linear-gradient(teal, orange, blue);
}

</style>
</head>
<body>
<div class="d1">
<h1 style="color:red;background-color:#ACE;position:absolute;">SYMPTOMS:</h1><br><br>
<p style:"font-size:20px;">
Doctors are learning new things about<br> 
this virus every day. So far,<br>
 we know that COVID-19 may not initially
<br> cause any symptoms for some people.<br>

You may carry the virus for 2 days or up to
<br> 2 weeksTrusted Source before you notice 
symptoms.<br><br>

<h2>Some common symptoms that have been
<br> specifically linked to COVID-19 include:</h2><br>
<p style:"font-size:25px";>
->shortness of breath<br>
->having a cough that gets more severe over time<br>
->a low-grade fever that gradually
<br> increases in temperature<br>
These symptoms may become more severe
<br> in some people.<br> <h2>Call emergency medical services 
if you or someone you care for
<br> have any of the following symptoms:</h2>
<p style:"font-size:25px;"
->trouble breathing<br>
->blue lips or face<br>
->persistent pain or pressure in the chest<br>
->confusion<br>
->excessive drowsiness<br>
</p>
</div>
<div class="d2">
<img src="download5.jpg" width="500px" height="500px">
</div>


<div class="d3">
<h1 style="color:red;background-color:#ACE;position:absolute;">PRECAUTIONS:</h1>
<p><br>
-->Avoid close contact with people
<br> who are sick. Maintain at least<br> 
three feet distance between yourself
<br> and anyone who is coughing or sneezing.<br>
-->Avoid touching your eyes, nose, and mouth.<br>
-->Stay home when you are sick.<br><br>
-->Cover your cough or sneeze with a tissue,<br> then dispose of the tissue safely.<br>
-->Clean and disinfect frequently-touched<br> objects and surfaces using <br>
a regular household <br>cleaning spray or wipe.<br>
-->Wearing a mask is not necessary<br> unless you are taking care<br>
of an infected person. <br>The Centers for Disease Control (CDC) does<br>
 recommend that only infected<br> people wear masks to prevent the 
spread of the virus.<br>
-->Wash your hands often with soap and water <br>for at least 20 seconds,<br>
especially after going to the bathroom,<br> before eating, and after
blowing <br>your nose, coughing, or sneezing.<br>
-->If soap and water are not readily available, <br>
use an alcohol-based<br> hand sanitiser with at least 60% alcohol.<br> 
Always wash hands with soap and<br> water when hands are visibly dirty.<br>
-->If you have a fever, cough<br> and difficulty breathing,<br> 
seek medical attention immediately.<br>
-->Keep in mind the travel advisory set out<br> by the Ministry of Health and Welfare.<br>
</p>
</div>
<div class="d4">
<img src="download6.png" width="500px" height="500px">
</div>

<div class="e1">
<h1 style="color:red;background-color:#ACE;position:absolute;">MEDICATION:</h1>
<br><br>
<p style="font-size:25px;">
<h2>Chloroquine to be tested for coronavirus treatment in the US</h2><br>
The President of the United States, Donald Trump, announced on 19 March<br> 
that chloroquine (hydroxychloroquine/Plaquenil), a drug used to treat<br> 
malaria and arthritis, was approved by the US Food and Drug Administration<br>
(FDA) to be tested as a treatment for COVID-19. Chloroquine is being tested<br>
in various clinical trials conducted by government agencies and academic institutions.<br>

Other antivirals drugs are also planned to be fast-tracked for testing for coronavirus.<br>
</p>
<p style="font-size:25px;">
<h2>Favilavir, the first approved coronavirus drug in China</h2>
The National Medical Products Administration of China has approved the use of<br>
 Favilavir, an anti-viral drug, as a treatment for coronavirus.<br> 
The drug has reportedly shown efficacy in treating the disease with<br>
 minimal side effects in a clinical trial involving 70 patients. <br>
The clinical trial is being conducted in Shenzhen, Guangdong province.<br>
</p>
</div>

<div class="e2">
<img src="download7.jpg" width="500px" height="500px">
</div>




<div class="e1">
<h2>Coronavirus vaccine by Medicago</h2><br>
<p style="font-size:20px">
Medicago is developing drug candidates against COVID-19
<br> after having produced Virus-Like Particles<br>
 (VLP) of the coronavirus. The company has formed <br>a collaboration with Laval University’s<br>
Infectious Disease Research Centre to develop <br>antibodies against SARS-CoV-2.v

The company’s research activities are being partly
<br> funded by the Canadian Institutes<br>
 for Health Research(CIHR).</p><br><br>

<h2>AT-100 by Airway Therapeutics</h2><br><p style="font-size:20px">
Airway Therapeutics is exploring its novel human <br>recombinant protein named AT-100 (rhSP-D) as a <br>
treatment for coronavirus. The company has announced<br> a filing with the Respiratory Diseases <br>
Branch of the National Institutes of Health to evaluate the drug.<br><br>

<h2>AT-100</h2><br>
 has shown efficacy in preclinical studies in <br>reducing inflammation and infection in the lungs,<br>
 while also generating an immune response against<br> various respiratory diseases.</p><br><br>

<h4>TZLS-501 by Tiziana Life Sciences</h2><br>
<p style="font-size:20px">
Tiziana Life Sciences is developing its monoclonal <br>antibody named TZLS-501 for the treatment of COVID-19.<br>
 TZLS-501 is a human anti-interleukin-6 receptor (IL-6R),<br> which helps in preventing lung damage and elevated <br>
levels of IL-6.<br>


The drug works by binding to IL-6R and depleting the amount<br> of IL-6 circulating in the body thereby reducing <br>
chronic lung inflammation.</P><br><br>
</div>

<div class="e2">
<img src="download8.jpg" width="500px" height="500px">
</div>

<br><br><br>

<div class="e1">
<h2 style="float:left;">OYA1 by OyaGen</h2><br>

OyaGen’s OYA1 has shown strong antiviral efficacy<br> against coronavirus in laboratory essays.<br>
 It was found to be more effective than chlorpromazine <br>HCl in inhibiting SARS-CoV-2 from replicating<br>
 in cell culture.<br>
OYA1 was earlier approved as an investigational new drug<br> for treating cancer but abandoned due to lack of efficacy.<br>
 OyaGen plans to conduct further research on the drug to <br>determine the efficacy in treating coronavirus.<br><br>

<h2>BPI-002 by BeyondSpring</h2> <br>

BeyondSpring’s BPI-002 is a small molecule agent indicated<br> for treating various infections including COVID-19.<br>
 It has the ability to activate CD4+ helper T cells and CD8+<br> cytotoxic T cells and generating an immune response in the body.<br>

If combined with another COVID-19 vaccine, the drug has <br>the ability to generate long-term protection against<br>
 viral infections. BeyondSpring has filed US patent <br>protection for the drug for treating viral infections.<br><br>

<h2>Altimmune’s intranasal coronavirus vaccine</h2><br>

An intranasal Covid-19 vaccine is being developed by<br> US-based clinical-stage biopharmaceutical company, Altimmune.<br>

Design and synthesis of the single-dose vaccine have<br> been completed, while animal testing will follow.<br>

The coronavirus vaccine is being developed based on a<br> vaccine technology platform that is similar to NasoVAX,<br>
 an influenza vaccine developed by Altimmune.<br><br>

<h2>INO-4800 by Inovio Pharmaceuticals and<br> Beijing Advaccine Biotechnology</h2><br>
Inovio Pharmaceuticals has collaborated with<br> Beijing Advaccine Biotechnology Company to advance the development <br>
of the former’s vaccine, INO-4800, as a novel coronavirus vaccine.<br> The company has started pre-clinical testing <br>
for clinical product manufacturing.<br>

</div>
<div class="c1">
<img src="download9.jpg" width="500px" height="500px">
</div>


<div id="grad"></div>

</body>
</html>